Norges Bank’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,462
| Closed | -$603K | – | 2086 |
|
|
2019
Q4 | $603K | Sell |
2,462
-1,706
| -41% | -$418K | ﹤0.01% | 2046 |
|
|
2019
Q3 | $1.44M | Sell |
4,168
-3,682
| -47% | -$1.27M | ﹤0.01% | 2013 |
|
|
2019
Q2 | $7.23M | Hold |
7,850
| – | – | ﹤0.01% | 1884 |
|
|
2019
Q1 | $12.5M | Hold |
7,850
| – | – | ﹤0.01% | 1725 |
|
|
2018
Q4 | $14.7M | Hold |
7,850
| – | – | 0.01% | 1572 |
|
|
2018
Q3 | $18.5M | Hold |
7,850
| – | – | 0.01% | 1574 |
|
|
2018
Q2 | $27M | Hold |
7,850
| – | – | 0.01% | 1306 |
|
|
2018
Q1 | $22.3M | Sell |
7,850
-215
| -3% | -$610K | 0.01% | 1360 |
|
|
2017
Q4 | $20.8M | Buy |
8,065
+3,395
| +73% | +$8.74M | 0.01% | 1446 |
|
|
2017
Q3 | $13.3M | Hold |
4,670
| – | – | 0.01% | 1647 |
|
|
2017
Q2 | $11M | Buy |
4,670
+547
| +13% | +$1.29M | ﹤0.01% | 1699 |
|
|
2017
Q1 | $10.4M | Buy |
4,123
+520
| +14% | +$1.31M | ﹤0.01% | 1729 |
|
|
2016
Q4 | $8.13M | Buy |
3,603
+552
| +18% | +$1.25M | ﹤0.01% | 1766 |
|
|
2016
Q3 | $7.3M | Buy |
3,051
+244
| +9% | +$584K | ﹤0.01% | 1777 |
|
|
2016
Q2 | $8.59M | Hold |
2,807
| – | – | ﹤0.01% | 1680 |
|
|
2016
Q1 | $8.91M | Hold |
2,807
| – | – | ﹤0.01% | 1629 |
|
|
2015
Q4 | $14.4M | Hold |
2,807
| – | – | 0.01% | 1362 |
|
|
2015
Q3 | $8.93M | Hold |
2,807
| – | – | ﹤0.01% | 1628 |
|
|
2015
Q2 | $11.2M | Sell |
2,807
-392
| -12% | -$1.57M | 0.01% | 1557 |
|
|
2015
Q1 | $12.8M | Sell |
3,199
-167
| -5% | -$667K | 0.01% | 1504 |
|
|
2014
Q4 | $16.5M | Buy |
3,366
+255
| +8% | +$1.25M | 0.01% | 1332 |
|
|
2014
Q3 | $12.6M | Sell |
3,111
-3,112
| -50% | -$12.7M | 0.01% | 1440 |
|
|
2014
Q2 | $25.2M | Buy |
6,223
+3,411
| +121% | +$13.8M | 0.01% | 1487 |
|
|
2014
Q1 | $12.8M | Hold |
2,812
| – | – | 0.01% | 1428 |
|
|
2013
Q4 | $9.85M | Hold |
2,812
| – | – | 0.01% | 1582 |
|
|
2013
Q3 | $11.6M | Buy |
2,812
+382
| +16% | +$1.57M | 0.01% | 1467 |
|
|
2013
Q2 | $9.62M | Buy |
+2,430
| New | +$9.62M | 0.01% | 1494 |
|